NCT05057013 A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05056402 An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05051722 Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer Status RECRUITING Phase N/A
NCT05047913 Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05045755 The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female Status UNKNOWN Phase N/A
NCT05033132 A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer Status WITHDRAWN Phase PHASE2
NCT05029258 Biomarkers for Clinical Hypoxia Evaluation in Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05021237 Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04989647 Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy Status RECRUITING Phase PHASE3
NCT04982237 A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04977453 GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT04974827 A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer Status UNKNOWN Phase PHASE2
NCT04974424 Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV Status UNKNOWN Phase N/A
NCT04974346 Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer Status RECRUITING Phase PHASE3
NCT04973904 Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer Status UNKNOWN Phase PHASE2
NCT04969445 The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female Status UNKNOWN Phase N/A